News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Diana Kwon | Apr 1, 2017
Meet some of the people featured in the April 2017 issue of
Opinion: More Biomarkers Needed for Cancer Immunotherapy
David Fabrizio | Apr 1, 2017
Measuring PD-L1 levels was a great start. Now we need to quantify more protein biomarkers, assess the tumor mutational landscape, and examine immune cell signatures, too.
Neoantigens Enable Personalized Cancer Immunotherapy
Stephen P. Schoenberger and Ezra Cohen | Apr 1, 2017
Tumors’ mutations can encode the seeds of their own destruction, in the form of immunogenic peptides recognized by T cells.
Targeting Tregs Halts Cancer’s Immune Helpers
Ruth Williams | Apr 1, 2017
New monoclonal antibodies kill both cancer-promoting immunosuppressive cells and tumor cells in culture.
Infographic: Targeting Cancer Antigens
Stephen P. Schoenberger and Ezra Cohen | Mar 31, 2017
Neoantigens may serve as valuable targets for new immunotherapies.
Infographic: Antibody Cancer Therapy
Ruth Williams | Mar 31, 2017
An experimental technique removes T cells that aid in vitro tumor growth.
Tasmanian Devil Cancer Immunotherapy
Bob Grant | Mar 13, 2017
Researchers in Australia claim to have successfully used immunotherapy to treat devil facial tumor disease.
Kite’s CAR T-Cell Therapy Success
Jef Akst | Mar 1, 2017
More than one-third of lymphoma patients in a Phase 2 trial were clear of disease at six months, and no new safety concerns arose since the company’s three-month follow up.
HIV Vaccines May Help Tamp Down Virus
Kerry Grens | Feb 24, 2017
A fraction of HIV patients in a small, uncontrolled study were able to stop antiretroviral therapy after receiving the immune boosters.
Toward Killing Cancer with Bacteria
Ruth Williams | Feb 8, 2017
Researchers employ an engineered microbe to destroy tumor cells in mice.